Tsumura & Co. (TYO:4540)

Market Cap	303.07B
Revenue (ttm)	181.92B
Net Income (ttm)	27.40B
Shares Out	74.34M
EPS (ttm)	363.48
PE Ratio	11.22
Forward PE	11.83
Dividend	152.00 (3.73%)
Ex-Dividend Date	Mar 30, 2026

Volume	219,500
Average Volume	315,315
Open	4,106.00
Previous Close	4,106.00
Day's Range	4,071.00 - 4,111.00
52-Week Range	3,306.00 - 4,775.00
Beta	-0.07
RSI	60.71
Earnings Date	Feb 6, 2026

About Tsumura & Co.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal and throat inflammation symptoms. It also offers over-the-counter Kampo medicines. The company was founded in 1893 and is headquartered in Tokyo, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 4,272
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4540

Financial Performance

In 2024, Tsumura & Co.'s revenue was 181.09 billion, an increase of 20.05% compared to the previous year's 150.85 billion. Earnings were 32.43 billion, an increase of 94.10%.